4th International Scientific and Family Conference July 2015

All of us on the board of ISMRD are honored and excited to once again sponsor a combined scientific and family conference for glycoprotein diseases in July 2015. The conference, Glycoproteinoses: Fourth International Conference on Advances in Pathogenesis and Therapy will be held on July 23–26 2015 in St. Louis, Missouri, USA. More detailed information on the conference agenda and registration information will be coming soon. We would like to invite all interested families and investigators and industry to attend this conference. If you wish to be added to the mailing list please send us your details.

Useful Links


ISMRD offers the following external sites for their potential usefullness in understanding Glycoprotein Storage Diseases. However, a listing here is not to be construed as an endorsement of that site's content by ISMRD and its Board of Directors.

Diagnostic Resources

Find diagnostic laboratories performing molecular and DNA analysis for establishing an initial diagnosis.

Directory-Search Sites

Specific Laboratories

Prenatal Testing

Sites that explain or perform prenatal testing.


Investigation of new therapeutic techniques for Glycoprotein Storage Diseases and their underlying causes has accelerated in this new millennium. The following sites may be explored for monitoring this activity’s impact on Glycoprotein Storage Diseases. 

Biopharmaceutical Companies

Clinical Trials

  • ClinicalTrials.gov: the National Institutes of Health's index of clinical trials proposed, under way and terminated.

Organizations & Agencies


Current therapies for Glycoprotein Storage Diseases are primarily supportive or palliative in nature. However, bone marrow and cord blood transplantation have shown initial success for patients with Alpha-Mannosidosis and Fucosidosis. Enzyme Replacement Therapy is currently in phase III clinical trials for Alpha-Mannosidosis.

Bone Marrow & Cord Blood Transplants

Enzyme Replacement Therapy (ERT)